ArticleThe oncologist2022

Efficacy of Infliximab Dose Escalation in Patients with Refractory Immunotherapy-Related Colitis: A Case Series.

Jessica P Harris et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.